couter

219A.THeartseed, Inc.

Nov 13, 2026 — Q3 2026 Earnings Release
Chart by TradingView

The schedule

  • Fri13Nov

    Quarterly earnings report evaluating recent revenue contraction to $1.5M and cash burn velocity.

  • Fri12Feb
  • Thu18Feb

    Expected topline data readout for the company's leading iPSC-derived cardiovascular therapy.

  • Thu25Mar

    Full-year financial results alongside crucial operating guidance and CapEx forecasts for FY27.

  • Fri14May
  • Tue15Jun

    Evaluation of regulatory pathways and regenerative medicine policies under President Trump's administration.

  • Fri13Aug